BARCLAYS PLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$23
+360.0%
33,791
+399.7%
0.00%
Q1 2023$5
+25.0%
6,762
+9.7%
0.00%
Q4 2022$4
-100.0%
6,162
-57.3%
0.00%
Q3 2022$14,000
-50.0%
14,4260.0%0.00%
Q2 2022$28,000
-68.2%
14,426
-17.4%
0.00%
Q1 2022$88,000
-84.3%
17,465
-76.5%
0.00%
Q4 2021$562,000
+128.5%
74,262
+138.3%
0.00%
Q3 2021$246,000
-50.8%
31,167
-13.7%
0.00%
Q2 2021$500,000
+39.7%
36,105
+111.3%
0.00%
Q1 2021$358,000
+29.2%
17,088
+2.2%
0.00%
Q4 2020$277,000
+9.9%
16,716
+12.8%
0.00%
Q3 2020$252,000
-34.2%
14,823
-35.8%
0.00%
Q2 2020$383,000
+133.5%
23,101
+62.6%
0.00%
Q1 2020$164,000
-8.9%
14,209
+16.3%
0.00%
Q4 2019$180,000
+102.2%
12,220
+87.2%
0.00%
Q3 2019$89,000
+78.0%
6,529
+70.7%
0.00%
Q2 2019$50,000
+614.3%
3,824
+403.2%
0.00%
Q1 2019$7,0007600.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$2,335,9571.93%
MPM ASSET MANAGEMENT LLC 3,131,388$2,329,7530.97%
MPM BioImpact LLC 3,196,707$2,378,3500.62%
Lion Point Capital, LP 169,283$125,9800.05%
Artal Group S.A. 1,000,000$7440.04%
Cormorant Asset Management, LP 540,600$4020.03%
KENNEDY CAPITAL MANAGEMENT LLC 529,934$394,3770.01%
Orbimed Advisors 621,218$462,3100.01%
Tekla Capital Management LLC 259,910$193,4250.01%
CM WEALTH ADVISORS LLC 50,354$290.01%
View complete list of HARPOON THERAPEUTICS INC shareholders